AAT Posts Earnings as Rady's $20M Buy Looms Over the Print

American Assets Trust delivered its Q3 results on Tuesday with the market's attention fixed less on the numbers than on the man who owns 38% of the company and spent $20 million buying the stock in the weeks before.

The insider story remains the defining fact here. Ernest Rady, Executive Chairman, made ten consecutive open-market purchases between late August and mid-September, accumulating 456,365 shares at prices ranging from $22.33 to $22.89. None were made under a pre-arranged 10b5-1 plan, meaning each was a discretionary decision. That cluster lifted his Schedule 13D/A stake to 38.0%, up from 37.1% previously, as last disclosed on 26 August. The 13D is an activist-level filing. Rady also controls American Assets, Inc., which holds a further 4.0% of shares. Combined, the Rady-linked position accounts for the dominant share of the company's register. The disclosure caveat applies: stakes are as last disclosed around the 5% threshold, and the actual current position may differ from what the August filing shows.

The lending market has loosened considerably since the pre-earnings note published earlier this week. Availability of shares to borrow now runs at 3,343%, up from 3,396% a week ago but broadly in the same range, meaning there are more than thirty shares available for every one already shorted. Short interest ticked up 5.6% over the week to 2.8% of the free float, and borrowing costs have eased back to 0.65% annualised from the 0.81% seen on Thursday. These are not numbers that suggest aggressive bearish conviction. With an ORTEX short score of 36.8 and a days-to-cover of 4.4, the short book looks more like routine index-tracking activity than a directional bet against the company.

Options positioning is equally relaxed. The put/call ratio sits at 0.07, barely above its 20-day average and well below the 52-week high of 1.01, placing it at just 0.16 standard deviations above the mean. That is as close to neutral as the options market gets, with calls vastly outnumbering puts. The stock itself is up 2.3% on the week to $21.22, modestly outperforming peers: PINE fell 8.1% over the same period and BNL dropped 3.3%, while EPRT gained 4.2%.

The Street is largely on the sidelines. The most recent analyst action came from Morgan Stanley's Richard Hill in July, who raised his price target to $24 while keeping an Underweight rating. That target implies about 13% upside from current levels, but the negative rating signal matters. The last available consensus mean target of $23.50 also sits above the current price, though the analyst data is now approaching three months old. Factor scores are unremarkable across the board: a short score rank of 49, a sector score of 50, and a days-to-cover rank of 69 tell a broadly neutral story. Valuation multiples show the EV/EBITDA at 6.4x, up roughly 0.2x over the past seven days, and the price-to-book at 1.5x.

The next scheduled earnings event is not until February 2027, so the next few days will be about how the market digests Tuesday's results against the backdrop of Rady's concentrated buying at prices above where the stock trades now.